Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Doctors should stop giving children codeine, according to a report by the American Academy of Pediatrics published in the journal Pediatrics.
A new report from Pricewaterhousecooper’s Health Research Institute (HRI) tries to identify “a vision for US New Health Economy” over the next decade, breaking down shifts in healthcare to five separate areas driving “seismic change.”
In 2008, healthcare providers were pushing for young women to get the HPV vaccine to reduce their chances of developing cervical cancers, and eight years later, it seems as though it worked.
Who needs SPF 50 when you can soon get SPF 5,000? Therapon Skin Health has developed silicon particles that absorb 98 percent of ultraviolet radiation.
Researchers from Harvard have been able to successfully developed a way to transport vaccines using molecular manufacturing to keep the medication safe for traveling.
Undergoing testing for sexually transmitted infections (STIs) can be a troubling ordeal for most people. The feeling of embarrassment can even prevent people from getting tested altogether. myLAB Box is hoping to ease the minds of patients by introducing a “Testing to Treatment” program, an at-home STI test that includes a free counseling with a physician.
CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
